Under the third phase of the corona vaccination campaign, registration on the Cowin Platform and the Aarogya Setu app for those above 18 years of age will begin from Wednesday, April 28. The eligible persons can then register themselves by visiting the (Cowin) portal. In view of the prevention of coronavirus infection, doses will be given to those above 18 years of age from May 1 for vaccination.
MyGovIndia tweeted that ignore the rumors about the date of registration, registration will start on Covin Platform and Arogya Setu app from April 28 and not April 24.
So far, only those above 45 years of age were allowed the vaccine. New cases of everyday infections in the country hit by the second wave of epidemics are setting a record of statistics. The figure for new cases has crossed 3 lakh on Thursday. People have to register online before going to the hospital for the first dose of the vaccine.
MyGovIndia tweeted that the third phase of vaccination will begin from May 1 for which the process of registration on the Aarogya Setu app and Covin platform is beginning. There is no app for the Covin site and registration can be done only through the website.
Don’t get misguided by rumours/news stating that registration for vaccination of 18+ citizens to start from 24th April 2021! The registrations will start on the #CoWIN platform and Aarogya Setu App from 28th April 2021 onwards. Stay informed, stay safe! #IndiaFightsCorona pic.twitter.com/i2SwCyRgFY
— MyGovIndia (@mygovindia) April 22, 2021
Do this Registration-
– Click Register/Sign in on Cowin Portal or Aarogya Setu App
– Enter the mobile number or Aadhaar number
-Get 10 digit OTP
– Enter OTP on site and click ‘Verify’
– Enter all details sought and click on the register
– This will be followed by the schedule option which will be completed after filling up the registration process.
The user will then get a reference ID (Reference ID) which will enable him to get a vaccination certificate. At present, two vaccines, Covaxin and Covishield are being provided under vaccination drive. Covaxin Hyderabad’s Bharat Biotech and Covishield have been developed by Oxford-AstraZeneca.